BREMAZOCINE

1-Ethyl-10-[(1-hydroxycyclopropyl)methyl]-13,13-dimethyl-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol

1-Ethyl-10-[(1-hydroxycyclopropyl)methyl]-13,13-dimethyl-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol

1-Éthyl-10-[(1-hydroxycyclopropyl)méthyl]-13,13-diméthyl-10-azatricyclo[7.3.1.0~2,7~]tridéca-2,4,6-trién-4-ol

2,6-Methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-((1-hydroxycyclopropyl)methyl)-11,11-dimethyl-

2,6-Methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-[(1-hydroxycyclopropyl)methyl]-11,11-dimethyl-

6-Ethyl-1,2,3,4,5,6-hexahydro-3-((1-hydroxycyclopropyl)methyl)-11,11-dimethyl-2,6-methano-3-benzazocin-8-ol

6-Ethyl-1,2,3,4,5,6-hexahydro-3-[(1-hydroxycyclopropyl)methyl]-11,11-dimethyl-2,6-methano-3-benzazocin-8-ol

6-ethyl-3-[(1-hydroxycyclopropyl)methyl]-11,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol

83829-76-9

BREMAZOCINE

6-Ethyl-3-((1-hydroxycyclopropyl)methyl)-11,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol

6-Ethyl-3-(1-hydroxy-cyclopropylmethyl)-11,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol

75684-07-0

dl-Bremazocine

Neuropeptides B/W receptor type 1

NPBW1_HUMAN

OPRD_HUMAN

OPRD_PIG

OPRK_CAVPO

OPRK_HUMAN

OPRM_CAVPO

OPRM_HUMAN

SGMR1_RAT

Δ-type opioid receptor

κ-type opioid receptor

μ-type opioid receptor